Levamisole in cases of E.N.L.
Levamisole, the anthelmintic drug was tried in ENL (Erythema Nodosum Leprosum) cases using double blind control trial in dosage of 150 mg/day on three consecutive days for three months. It was found that levamisole was not effective in ENL cases and no severe side effect was seen in these cases.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004893:Erythema Nodosum / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D007978:Levamisole